目前和新兴的单克隆抗体用于治疗儿童家族性高胆固醇血症
M Doortje Reijman1, D Meeike Kusters1, Albert Wiegman1
1Department of Pediatrics, Amsterdam Cardiovascular Sciences, Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
Expert opinion on biological therapy
|March 19, 2024
概括
针对PCSK9的单克隆抗体可在标准疗法失败时为异性家族高胆固醇血症 (HeFH) 的儿童提供先进的降脂治疗. 这些治疗方法,包括evolocumab和alirocumab,在控制高LDL-C水平方面是安全有效的.
科学领域:
- 心血管医学 心血管医学
- 遗传学 是一个遗传学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 异卵性家族性高胆固醇血症 (HeFH) 是一种遗传性疾病,导致高的LDL-C水平和早发性心血管疾病风险.
- 儿童的早期诊断和治疗对于减轻长期健康后果至关重要.
- 标准的降脂疗法,如他类药物和ezetimibe,对于所有儿科HeFH患者来说并不普遍有效.
研究的目的:
- 审查当前和新兴的单克隆抗体疗法用于儿科HeFH.
- 提供PCSK9抑制剂用于儿童HeFH的管理的概述.
主要方法:
- 对儿童治疗HeFH的可用和正在研究的单克隆抗体的文献综述.
- 对儿童群体PCSK9抑制剂的安全性和疗效数据的分析.
主要成果:
- 当口服疗法不足或不能耐受时,PCSK9抑制剂 (evolcumab,alirocumab) 对患有HeFH的儿童有效且安全.
- 埃沃洛库马布已被批准用于10岁以上的儿童,而阿利罗库马布用于8岁以上的儿童.
- 高成本需要对这些先进疗法进行谨慎的患者选择.
结论:
- 单克隆抗体,特别是PCSK9抑制剂,对于那些对标准治疗无反应的HEFH儿童来说,是一个重要的治疗选择.
- 这些药物的使用需要仔细考虑成本效益和患者选择.
- 继续在这一领域的研究和开发对于改善儿科心血管健康的结果至关重要.
相关概念视频
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
660
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
660
01:31Hybridoma Technology
14.7K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.7K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
294
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
294
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K